Pfizer agrees to supply EU with up to 300m doses of coronavirus vaccine
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] Pfizer and German partner BioNTech said on Wednesday they had reached an agreement with the European Commission to supply up to 300 million doses of their experimental coronavirus vaccine.
Deliveries are expected to start by the end of this year, the companies said.
The companies said on Monday their Covid-19 vaccine was more than 90 per cent effective based on initial trial results, and the European Commission had hours later said it would soon sign the contract with the companies.
The companies have a US$1.95 billion contract with the US government to deliver 100 million vaccine doses beginning this year.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
